Form 4 for ANIP ANI PHARMACEUTICALS INC
Accepted 2024-04-02 00:00:00 ET · period of report 2024-04-01 · accession 0001871002-24-000008 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2024-04-02 | 2024-04-01 | ANIP | Gassert Chad | SVP - CORP. DEV, STRATEGY | S - Sale | $67.25 | -20.0K | 253.2K | -7% | -$1.34M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-04-01 | S | D | 20,000 | $67.25 | 253,226 | I Held by Chali Properties LLC | — | — | (F2) The shares were sold in multiple trades at prices ranging from $66.50 to $69.05. The price reported above reflects the weighted average sales price. (F3) The reporting person holds voting and dispositive power over the shares held by Chali Properties LLC. |